Literature DB >> 11833521

Meeting the therapeutic challenge of the patient with osteoarthritis.

Cathryn Todd1.   

Abstract

OBJECTIVE: To discuss the diagnosis of osteoarthritis and the efficacy of available pharmacologic and nonpharmacologic treatment options. DATA SOURCES: Published reports on the diagnosis and treatment of osteoarthritis were identified through a MEDLINE search of English-language journal articles using a focused title search for the keywords acetaminophen, nonsteroidal anti-inflammatory, COX-2 nonsteroidal, opioids, capsaicin, tramadol, glucosamine, hyaluronic acid, and osteoarthritis and by reviewing the bibliographies of selected reviews. The American College of Rheumatology (ACR) guidelines, as updated in September 2000, for the treatment of osteoarthritis of the hip and knee were analyzed with appropriate references to clinical and scientific studies, review articles, and other published guidelines. DATA SYNTHESIS: Each patient's medical history and level of pain should decide the most appropriate treatment. Nonpharmacologic therapies should always be included in the treatment regimen. If further pain management is required, the most appropriate pharmacologic treatments are acetaminophen or nonsteroidal anti-inflammatory drugs for mild-to-moderate pain, tramadol or opioid combinations for moderate-to-moderately severe pain, and opioids for severe pain. Adjunctive treatments, intraarticular injections, and surgery are also viable options for some patients.
CONCLUSION: If used properly, the ACR guidelines for the treatment of osteoarthritis are important tools in the care of the patient with this disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11833521     DOI: 10.1331/108658002763538107

Source DB:  PubMed          Journal:  J Am Pharm Assoc (Wash)        ISSN: 1086-5802


  2 in total

1.  Lumiracoxib is effective in the treatment of osteoarthritis of the knee: a prospective randomized 13-week study versus placebo and celecoxib.

Authors:  Roy Fleischmann; Eric Sheldon; José Maldonado-Cocco; Dipen Dutta; Sue Yu; Victor S Sloan
Journal:  Clin Rheumatol       Date:  2005-08-13       Impact factor: 2.980

2.  Chondroprotective activity of N-acetylglucosamine in rabbits with experimental osteoarthritis.

Authors:  A R Shikhman; D Amiel; D D'Lima; S-B Hwang; C Hu; A Xu; S Hashimoto; K Kobayashi; T Sasho; M K Lotz
Journal:  Ann Rheum Dis       Date:  2005-01       Impact factor: 19.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.